Printer Friendly

ProMetic Life Sciences Acquires Affinity Chromatography.

Burtonsville, MD, 5/13/99-ProMetic Life Sciences, Inc. acquired 100% ownership of Affinity Chromatography Limited in the first quarter of 1999. ACL held a 34% interest in ProMetic BioSciences, Inc., a subsidiary of PLI. PLI now owns 100% of PBI, as well as ACL. ACL develops high-performance affinity media for the isolation and purification of biological compounds and therapeutic proteins.

Affinity Chromatography's protein purification technology produces high yield and purity for lower costs and will allow ProMetic to offer more efficient, high quality custom media to its customers, particularly pharmaceutical companies.
COPYRIGHT 1999 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:ProMetic Life Sciences Acquires Affinity Chromatography.
Publication:Instrument Business Outlook
Geographic Code:1USA
Date:May 31, 1999
Previous Article:Millipore Buys Bioprocessing Corporation.
Next Article:Dyson-Kissner-Moran to Buy Optek Technology.

Related Articles Makes Two Acquisitions.
The "other" liquid chromatography.
Companies. (Random Samples).
Pall to acquire Ciphergen's process chromatography business.
Practical high-performance liquid chromatography, 4th ed.
Encyclopedia of chromatography, 2d ed.; 2v.
Enzymes; biochemistry, biotechnology and clinical chemistry, 2d ed.
Merck acquires HPLC column company.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters